Source: Inspirata, Inc.

Visit Inspirata at CAP, ‘The Pathologists’ Meeting,’ Next Week

Inspirata will be demonstrating its bi-directionally integrated digital pathology cockpit that provides a fully immersive environment where pathologists can easily access all the information they need to comprehensively review and diagnose cancer cases right.

Tampa, FL, Oct. 06, 2017 (GLOBE NEWSWIRE) -- Cancer informatics and digital pathology workflow solution provider Inspirata®, Inc. announced today that it will be exhibiting in Booth #802 at the College of American Pathologists (CAP) Annual Meeting at the Gaylord National Resort and Convention Center in National Harbor, MD, October 8 – 11.

Attendees at CAP’s annual meeting can visit Booth #802 to learn more about Inspirata’s end-to-end digital pathology workflow solution and its fully immersive Digital Pathology Cockpit where pathologists can comprehensively review and diagnose patient cases, write diagnostic reports and submit those reports to the LIS.

“The focus of our cockpit roadmap is to continue to add novel features and develop integrations with third-party tools and technologies that enable pathologists to spend more of their time diagnosing disease rather than searching for and retrieving information from different sources and systems,” says Inspirata Executive Vice President and Founder, Mark Lloyd, PhD, MSM. “We’re very excited to have CAP as the forum to demonstrate two recent integrations to our cockpit, including a bi-directional integration with a SCC Soft Computer Lab Information System and an integration with Elsevier’s comprehensive anatomic and clinical pathology diagnostic decision support tools. These new integrations will give pathologists the information they need to formulate their diagnoses much faster because it will be a simple keystroke away in our cockpit.”

Inspirata also will be announcing at CAP that it has expanded the portfolio of scanning devices it can deliver to its clients as part of its end-to-end digital pathology workflow solution. This includes the addition of best-of-breed scanners for a diverse set of clinical applications ranging from large scanners for high-volume scanning centers to more specialized small-footprint instruments that provide specialized uses including oil immersion, live microscopy and fluorescence.

Inspirata’s end-to-end digital pathology workflow solution employs a unique, “Solution-as-a-Service” business model designed to help cancer institutions overcome the financial barrier to adoption by making the upfront capital investment in the digital pathology instrumentation, hardware, software and storage. Inspirata also does the workflow requirements analysis and complete project planning and program management. Integration services, operational staffing and management, and technical support are included along with scan lab staffing to do retrospective and prospective histopathology slide scanning, as well as diagnostic cockpits for each of the cancer center’s pathologists.

About the College of American Pathologists

As the world’s largest organization of board-certified pathologists and leading provider of laboratory accreditation and proficiency testing programs, the College of American Pathologists (CAP) serves patients, pathologists and the public by fostering and advocating excellence in the practice of pathology and laboratory medicine worldwide. For more information, read the CAP annual report at

About Inspirata, Inc.

Inspirata®, Inc. offers the most comprehensive cancer diagnostics workflow solution available for precision diagnosis today. The solution, which employs a unique “solution-as-a-service” business and delivery model, accelerates anatomic and molecular pathology workflows and facilitates whole slide imaging and image analytics, prognostic and predictive assays, remote consultations and tumor boards. This comprehensive solution includes an Enterprise Service Bus (ESB) to help to solve interoperability issues and a Natural Language Processing Engine (NLP) for structuring data. Inspirata amalgamates this structured data into a central multi-institutional and multi-modal big data cancer repository for clinical, research and educational purposes. Its use will extend to physicians, patients, researchers and pharma among others. This comprehensive solution facilitates a modern precision diagnosis to build a strong foundation for precision medicine. For more information, please visit or contact


A photo accompanying this announcement is available at

Marjorie Bulone
Inspirata, Inc.